JP2023540240A5 - - Google Patents

Info

Publication number
JP2023540240A5
JP2023540240A5 JP2023513672A JP2023513672A JP2023540240A5 JP 2023540240 A5 JP2023540240 A5 JP 2023540240A5 JP 2023513672 A JP2023513672 A JP 2023513672A JP 2023513672 A JP2023513672 A JP 2023513672A JP 2023540240 A5 JP2023540240 A5 JP 2023540240A5
Authority
JP
Japan
Prior art keywords
compounds
dotatate
lutetium
octreotate
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023513672A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023540240A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2021/000589 external-priority patent/WO2022043754A2/en
Publication of JP2023540240A publication Critical patent/JP2023540240A/ja
Publication of JP2023540240A5 publication Critical patent/JP2023540240A5/ja
Pending legal-status Critical Current

Links

JP2023513672A 2020-08-27 2021-08-27 放射性薬剤および方法 Pending JP2023540240A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063071138P 2020-08-27 2020-08-27
US63/071,138 2020-08-27
PCT/IB2021/000589 WO2022043754A2 (en) 2020-08-27 2021-08-27 Radiopharmaceutical and methods

Publications (2)

Publication Number Publication Date
JP2023540240A JP2023540240A (ja) 2023-09-22
JP2023540240A5 true JP2023540240A5 (https=) 2024-09-04

Family

ID=80352743

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023513672A Pending JP2023540240A (ja) 2020-08-27 2021-08-27 放射性薬剤および方法

Country Status (9)

Country Link
US (2) US11439714B2 (https=)
EP (1) EP4204011A4 (https=)
JP (1) JP2023540240A (https=)
KR (1) KR20240121161A (https=)
CN (1) CN116528904A (https=)
AU (1) AU2021330382A1 (https=)
CA (1) CA3190855A1 (https=)
TW (1) TW202227143A (https=)
WO (1) WO2022043754A2 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018204872A2 (en) * 2017-05-05 2018-11-08 Fusion Pharmaceuticals Inc. Igf-1r monoclonal antibodies and uses thereof
EP4178628A4 (en) 2020-07-13 2025-04-02 Point Biopharma, Inc. RADIOPHARMACEUTICALS AND PROCEDURES
JP2025505307A (ja) * 2022-03-02 2025-02-21 ポイント・バイオファーマ・インコーポレイテッド 放射性医薬品及び方法
CN115015441B (zh) * 2022-07-14 2023-08-18 原子高科股份有限公司 一种测定镥[177Lu]氧奥曲肽注射液中稳定剂含量的方法
US12514939B2 (en) 2024-02-14 2026-01-06 Alpha-9 Oncology, Inc. Stable radiopharmaceutical compositions and uses thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1096278A (en) 1913-08-25 1914-05-12 American Radiator Co Service-outlet fitting for pneumatic cleaning systems.
US6066309A (en) 1996-02-02 2000-05-23 Rhomed Incorporated Post-labeling stabilization of radiolabeled proteins and peptides
US6358245B1 (en) 1998-02-19 2002-03-19 Curon Medical, Inc. Graphical user interface for association with an electrode structure deployed in contact with a tissue region
US7297143B2 (en) 2003-02-05 2007-11-20 Arthrocare Corporation Temperature indicating electrosurgical apparatus and methods
JP5139678B2 (ja) 2003-07-24 2013-02-06 ブラッコ・イメージング・ソシエタ・ペル・アチオニ 安定な放射性医薬品組成物およびその製法
JP2018518526A (ja) * 2015-06-25 2018-07-12 アドバンスド アクセレレーター アプリケーションズ ソマトスタチン受容体を過剰発現する神経内分泌腫瘍を処置する方法
CA3035415A1 (en) 2016-05-23 2017-11-30 Imperial Innovations Limited Surgical instrument, robotic arm and control system for a robotic arm
US10537399B2 (en) 2016-08-16 2020-01-21 Ethicon Llc Surgical tool positioning based on sensed parameters
US10537394B2 (en) 2016-12-19 2020-01-21 Ethicon Llc Hot device indication of video display
US10596276B2 (en) * 2018-07-25 2020-03-24 Advanced Accelerator Applications (Italy) S.R.L. Stable, concentrated radionuclide complex solutions
US10596278B2 (en) * 2018-07-25 2020-03-24 Advanced Accelerator Applications (Italy) S.R.L. Stable, concentrated radionuclide complex solutions
WO2020064693A1 (en) * 2018-09-25 2020-04-02 Advanced Accelerator Applications (Italy) Srl Combination therapy
CA3159337A1 (en) * 2018-10-31 2020-05-07 Advanced Accelerator Applications (Italy) Srl Methods for synthesis of radionuclide complex

Similar Documents

Publication Publication Date Title
JP2023540240A5 (https=)
JP2023539990A5 (https=)
TWI875842B (zh) 放射性金屬標定抗體、其製造方法、螯合連接子、及肽修飾抗體
JP2008546804A (ja) 造影剤として用いるためのリガンドの放射性標識ペグ化
Liu et al. A new 18 F-heteroaryltrifluoroborate radio-prosthetic with greatly enhanced stability that is labelled by 18 F–19 F-isotope exchange in good yield at high specific activity
JP2023552180A5 (https=)
CN1484534A (zh) 稳定的放射性药物组合物
EP0199260A2 (en) Boronic acid adducts of technetium-99M dioxime complexes
JP2025116040A (ja) 放射性金属錯体の製造方法
CN114423421A (zh) Psma显像剂的制剂
US20210128758A1 (en) Composition Containing a Somatostatin Analogue for Radiopharmaceutical Use
US20230302169A1 (en) Astatine solution and method for producing same
CN115702009A (zh) 用于放射性标记psma结合配体的方法及其试剂盒
RU2568888C1 (ru) СПОСОБ И СОСТАВ ДЛЯ ПОЛУЧЕНИЯ РЕАГЕНТА ДЛЯ РАДИОНУКЛИДНОЙ ДИАГНОСТИКИ НА ОСНОВЕ МЕЧЕННОЙ ТЕХНЕЦИЕМ-99m 5-ТИО-D-ГЛЮКОЗЫ
EP0096932B1 (en) Process for making a lyophilized product for use in skeletal imaging
CN1437486A (zh) 放射药物的稳定剂
CA2634666C (en) Stabilized compositions and methods for radiolabeling pharmaceuticals with alpha-particle emitters
EP1401507A2 (en) Stabilization of radionuclide-containing compositions
Bubenshchikov et al. The impact of zirconium‐89 solution formulation on the efficiency of [89Zr] Zr‐deferoxamine synthesis
CN120733077B (zh) 药物组合物及其制备方法与药物制剂
EP3773553A1 (en) Formulations and kits for radiotherapy and diagnostic imaging
WO2023171617A1 (ja) 電解酸化反応による放射標識アリール化合物の製造方法
KR20230088764A (ko) 항her2 항체의 방사성 복합체, 및 방사성 의약
EP4516780A1 (en) Method for producing radioactive metal complex
TW202515624A (zh) 用於治療碳酸酐酶ix陽性疾病之方法之放射性標記化合物